Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • Log out
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
e-Letters: Observations

Increases in Biomarkers of Hyperglycemia With Age in the Atherosclerosis Risk in Communities (ARIC) Study

  1. Bethany Warren1,
  2. Andreea M. Rawlings1,
  3. Alexandra K. Lee1,
  4. Morgan Grams1,2,
  5. Josef Coresh1 and
  6. Elizabeth Selvin1⇑
  1. 1Department of Epidemiology and Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
  2. 2Johns Hopkins University School of Medicine, Baltimore, MD
  1. Corresponding author: Elizabeth Selvin, eselvin{at}jhu.edu.
Diabetes Care 2017 Aug; 40(8): e96-e97. https://doi.org/10.2337/dc17-0075
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

The American Diabetes Association’s Standards of Medical Care in Diabetes—2017 states that age should be “taken into consideration” when diagnosing diabetes with HbA1c (1). Nonetheless, it is unclear how this recommendation might be implemented. Population studies demonstrate that HbA1c increases with age, which some experts have suggested may be due to nonglycemic factors like alterations in red cell turnover or hemoglobin glycation (2–4). However, prior studies lack concurrent comparisons across nonhemoglobin-related markers of hyperglycemia. We evaluated increases with age in fructosamine and glycated albumin—hemoglobin-independent measures of hyperglycemia—in comparison with HbA1c and fasting glucose in the community-based Atherosclerosis Risk in Communities (ARIC) study.

We conducted serial cross-sectional analyses at visit 2 (1990–1992; n = 11,632) and visit 5 (2011–2013; n = 3,876), excluding individuals with diagnosed diabetes. We performed adjusted linear regression of z scores of each biomarker (standardized to visit 2) on age to allow head-to-head comparisons of the associations.

Age was significantly correlated with all biomarkers of hyperglycemia at visit 2 (Fig. 1). In middle age (visit 2), we observed increases in HbA1c with age, comparable increases in fructosamine and glycated albumin, and some increase in fasting glucose, with modest impact of adjustment for sex, race center (white, Minneapolis, MN; black, Jackson, MS; white, Washington County, MD; black, Forsyth County, NC; white, Forsyth County, NC; as defined by the ARIC study design), BMI, and BMI2. At visit 5 among older adults (21 years later), increases with age were less evident for fasting glucose and HbA1c compared with fructosamine and glycated albumin. Associations of age with HbA1c, fructosamine, and glycated albumin at both visits persisted after further adjustment for fasting glucose.

Figure 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1

Scatterplots with linear predictions, Pearson correlation coefficients, and unadjusted β coefficients (95% CIs) from linear regressions of z scores of markers of hyperglycemia (standardized to visit 2) on age (visit 2: 1990–1992 and visit 5: 2011–2013). HbA1c (A), fasting glucose (B), fructosamine (C), and glycated albumin (D). Black circles, visit 2 biomarker values; white line, visit 2 linear prediction; white circles, visit 5 biomarker values; black line, visit 5 linear prediction. *P < 0.05, **P < 0.001.

The magnitude of the association we observed between HbA1c and age, particularly in middle age (0.11% [1.2 mmol/mol] per 10 years of age), was similar to that in other studies (2–4). Prior investigations adjusted for glucose to account for glycemia and attributed associations to nonglycemic hemoglobin-related factors. However, although HbA1c and fasting glucose are highly related, they represent different glycemic constructs. We observed increases in HbA1c, fructosamine, and glycated albumin independent of fasting glucose, suggesting that increases may be primarily glycemic or that putative nonglycemic factors may influence nonhemoglobin biomarkers.

The heterogeneity of dysglycemia across the life span may offer some explanation for the less consistent associations of age across the hyperglycemia biomarkers. Impaired insulin secretion is common in older age. As HbA1c, fructosamine, and glycated albumin reflect postprandial glucose excursions in addition to fasting concentrations, their stronger associations with age as compared with fasting glucose could reflect that impaired glucose tolerance is more common than impaired fasting glucose in this population (5).

Similar to previous investigations, our assessment is limited by its cross-sectional nature. Additionally, our analyses of older adults could be subject to selection bias. Study strengths include the community-based sample, broad age range, and measurements at different time points in the life span.

In conclusion, we observed higher HbA1c at older ages but also saw comparable associations for other (nonhemoglobin-related) biomarkers of hyperglycemia. Our results provide some evidence that the age associations with HbA1c, fasting glucose, fructosamine, and glycated albumin may reflect increases in the prevalence of hyperglycemia in aging.

Article Information

Ackowledgments. The authors thank the staff and participants of the ARIC study for their important contributions. Reagents for the glycated albumin assays were donated by the Asahi Kasai Pharma Corporation. Reagents for the fructosamine assays were donated by Roche Diagnostics.

Funding. ARIC is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C. B.W., A.M.R., and A.K.L. were supported by National Institutes of Health National Heart, Lung, and Blood Institute grant T32HL007024. This research was supported by National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases grant R01DK089174, and E.S. was also supported by K24DK106414.

Duality of Interest. No potential conflicts of interest relevant to this article were reported.

Author Contributions. B.W. and E.S. designed the study, researched the data, and wrote the manuscript. A.M.R., A.K.L., M.G., and J.C. all provided meaningful contributions to the revision of the manuscript. E.S. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

  • Received January 12, 2017.
  • Accepted April 22, 2017.
  • © 2017 by the American Diabetes Association.
http://www.diabetesjournals.org/content/license

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.

References

  1. ↵
    1. American Diabetes Association
    . Standards of Medical Care in Diabetes—2017. Diabetes Care 2017;40(Suppl. 1):S1–S135
    OpenUrlFREE Full Text
  2. ↵
    1. Pani LN,
    2. Korenda L,
    3. Meigs JB, et al
    . Effect of aging on A1C levels in persons without diabetes: evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001–2004. Diabetes Care 2008;31:1991–1996
    OpenUrlAbstract/FREE Full Text
    1. Dubowitz N,
    2. Xue W,
    3. Long Q, et al
    . Aging is associated with increased HbA1c levels, independently of glucose levels and insulin resistance, and also with decreased HbA1c diagnostic specificity. Diabet Med 2014;31:927–935
    OpenUrlCrossRefPubMed
  3. ↵
    1. Ravikumar P,
    2. Bhansali A,
    3. Walia R,
    4. Shanmugasundar G,
    5. Ravikiran M
    . Alterations in HbA1c with advancing age in subjects with normal glucose tolerance: Chandigarh Urban Diabetes Study (CUDS). Diabet Med 2011;28:590–594
    OpenUrlCrossRefPubMed
  4. ↵
    1. Kalyani RR,
    2. Egan JM
    . Diabetes and altered glucose metabolism with aging. Endocrinol Metab Clin North Am 2013;42:333–347
    OpenUrlCrossRefPubMed
View Abstract
PreviousNext
Back to top
Diabetes Care: 40 (8)

In this Issue

August 2017, 40(8)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Increases in Biomarkers of Hyperglycemia With Age in the Atherosclerosis Risk in Communities (ARIC) Study
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Increases in Biomarkers of Hyperglycemia With Age in the Atherosclerosis Risk in Communities (ARIC) Study
Bethany Warren, Andreea M. Rawlings, Alexandra K. Lee, Morgan Grams, Josef Coresh, Elizabeth Selvin
Diabetes Care Aug 2017, 40 (8) e96-e97; DOI: 10.2337/dc17-0075

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Increases in Biomarkers of Hyperglycemia With Age in the Atherosclerosis Risk in Communities (ARIC) Study
Bethany Warren, Andreea M. Rawlings, Alexandra K. Lee, Morgan Grams, Josef Coresh, Elizabeth Selvin
Diabetes Care Aug 2017, 40 (8) e96-e97; DOI: 10.2337/dc17-0075
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Article Information
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Early Worsening of Diabetic Nephropathy in Type 2 Diabetes After Rapid Improvement in Chronic Severe Hyperglycemia
  • Continuous Glucose Monitoring in the Operating Room and Cardiac Intensive Care Unit
  • Vertebral Ischemic Necrosis in Diabetic Lumbosacral Radiculoplexus Neuropathy
Show more e-Letters: Observations

Similar Articles

Subjects

  • Epidemiology-Clinical-Diagnosis and Screening

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.